Isolated Agnathia-Otocephaly Complex Diagnosed Prenatally for Ex-Utero Intrapartum Treatment: A Case Report.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
11 May 2023
Historique:
medline: 12 5 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: epublish

Résumé

BACKGROUND Agnathia-otocephaly complex (AOC) is a rare congenital malformation due to a first-branch arch disorder and has been considered lethal. However, milder variants of the isolated type of AOC have been reported as nonlethal. The ex-utero intrapartum treatment (EXIT) procedure is basically indicated for a fetus with a high risk of airway obstruction immediately after birth; it is not indicated for all AOC cases but is chosen to treat cases until the airway can be evaluated to achieve a better prognosis. CASE REPORT A 37-year-old woman was referred with reported fetal facial deformity and polyhydramnios at 27 weeks of gestation. Our fetal ultrasound scans showed agnathia, microstomia, and synotia, but not holoprosencephaly. Isolated AOC was diagnosed prenatally. Magnetic resonance imaging and microbubble tests revealed delayed fetal lung maturation, although it was not completely unmatured. With patient agreement, an emergency cesarean section with EXIT was performed because of clinical chorioamnionitis at 35 weeks of gestation. Tracheostomy was attempted for 16 min during EXIT and was completed 4 min after delivery. Despite this, the neonate died 12 h after delivery from severe respiratory failure and a tension pneumothorax caused by a hypoplastic lung. CONCLUSIONS There is controversy surrounding the non-lethality of all isolated AOC cases and the non-contraindication of EXIT procedures. Our case was estimated as the milder variant, and the EXIT procedure was indicated; however, the neonate died of the hypoplastic lung. The evaluation methods of lung maturation are inconsistent, and the indication of the invasive EXIT procedure must be carefully considered.

Identifiants

pubmed: 37165610
pii: 939016
doi: 10.12659/AJCR.939016
pmc: PMC10184467
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e939016

Références

Am J Med Genet. 2002 Oct 1;112(2):203-8
pubmed: 12244557
J Obstet Gynaecol India. 2022 Aug;72(4):364-368
pubmed: 35923505
Can J Anaesth. 2007 Mar;54(3):171-5
pubmed: 17331927
Eur J Med Genet. 2010 Nov-Dec;53(6):358-66
pubmed: 20849990
Cell Tissue Res. 2017 Mar;367(3):427-444
pubmed: 28144783
J Craniofac Surg. 2015 Nov;26(8):2387-92
pubmed: 26517463
Transl Pediatr. 2021 Aug;10(8):2131-2135
pubmed: 34584884
AJR Am J Roentgenol. 2018 Aug;211(2):432-438
pubmed: 29894217
Am J Med Genet A. 2020 Oct;182(10):2409-2416
pubmed: 32783348
J Pediatr Surg. 2020 Jul;55(7):1188-1195
pubmed: 32151401
Jpn J Radiol. 2018 Jul;36(7):444-449
pubmed: 29767297
Fetal Diagn Ther. 2009;26(3):162-6
pubmed: 19776546
Gene. 2012 Feb 15;494(1):124-9
pubmed: 22198066
Semin Pediatr Surg. 2019 Aug;28(4):150820
pubmed: 31451172
Pediatr Pulmonol. 2005 Nov;40(5):445-8
pubmed: 16161157

Auteurs

Tokumasa Suemitsu (T)

Department of Obstetrics/Gynecology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Ami Takesawa (A)

Department of Obstetrics/Gynecology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Mayu Hosokawa (M)

Department of Obstetrics/Gynecology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Takahiro Mitani (T)

Department of Obstetrics/Gynecology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Mizuho Kadooka (M)

Department of Obstetrics/Gynecology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Yoshiaki Furusawa (Y)

Department of Obstetrics/Gynecology, Kameda Medical Center, Kamogawa, Chiba, Japan.

Motoyoshi Kawataki (M)

Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan.

Satoshi Dohi (S)

Department of Obstetrics/Gynecology, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH